Search

Your search keyword '"Ferrero, Marta"' showing total 145 results

Search Constraints

Start Over You searched for: Author "Ferrero, Marta" Remove constraint Author: "Ferrero, Marta"
145 results on '"Ferrero, Marta"'

Search Results

2. BaBELI 2011

3. Spinocerebellar ataxia 38: structure–function analysis shows ELOVL5 G230V is proteotoxic, conformationally altered and a mutational hotspot

9. Atención a las personas con dislexia en la formación universitaria: recomendaciones para la gestión institucional y la práctica docente

10. Attention for people with dyslexia in higher education: Recommendations at institutional and teaching practice level

11. Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity

12. Spinocerebellar Ataxia Tethering PCR: A Rapid Genetic Test for the Diagnosis of Spinocerebellar Ataxia Types 1, 2, 3, 6, and 7 by PCR and Capillary Electrophoresis

13. Exome sequencing in children of women with skewed X-inactivation identifies atypical cases and complex phenotypes

15. Escuela de moda, diseño y oficios asociados

16. CAPRIN1 haploinsufficiency causes a neurodevelopmental disorder with language impairment, ADHD and ASD

17. AA-amyloidosis in cats (Felis catus) housed in shelters

19. AA-amyloidosis in cats (Felis catus) housed in shelters

20. Spinocerebellar ataxia 38: structure-function analysis shows ELOVL5 G230V is proteotoxic, conformationally altered and a mutational hotspot

24. CAPRIN1 haploinsufficiency causes a neurodevelopmental disorder with language impairment, ADHD and ASD

25. El ferrocarril como herramienta para el desarrollo rural: propuesta para la línea de Zamora a Puebla de Sanabria.

26. AA-amyloidosis in cats (Felis catus) housed in shelters

27. CAPRIN1 haploinsufficiency causes a neurodevelopmental disorder with language impairment, ADHD and ASD.

30. Especificidades presupuestarias de los créditos del Mecanismo de Recuperación y Resiliencia

33. A high‐content drug screening strategy to identify protein level modulators for genetic diseases: A proof‐of‐principle in autosomal dominant leukodystrophy

36. Desarrollo e implementación de una aplicación web para niños con Trastorno de Espectro Autista

37. ADRION 2021-2027: Analysis of the territorial challenges, needs and potentials of the Adriatic-Ionian Region and strategic options for post-2020 ADRION Programme – Interreg V-B Adriatic – Ionian Cooperation Programme 2014-2020 (Bologna - Italy, 2020)

38. The effectiveness of refutation texts to correct misconceptions among educators

39. Desarrollo e implementación de una aplicación web para niños con Trastorno de Espectro Autista

40. SCA Tethering-PCR: A Rapid Genetic Test for the Diagnosis of SCA1-3, 6, and 7 by PCR and Capillary Electrophoresis

43. Allele-specific silencing as treatment for gene duplication disorders: proof-of-principle in autosomal dominant leukodystrophy

44. Allele-specific silencing as treatment for gene duplication disorders: proof-of-principle in autosomal dominant leukodystrophy

45. Allele-specific silencing as treatment for gene duplication disorders: proof-of-principle in autosomal dominant leukodystrophy

46. Allele-specific silencing as treatment for gene duplication disorders: proof-of-principle in autosomal dominant leukodystrophy

47. A high‐content drug screening strategy to identify protein level modulators for genetic diseases: A proof‐of‐principle in autosomal dominant leukodystrophy.

48. Mice harboring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.

50. A novel homozygous change ofCLCN2(p.His590Pro) is associated with a subclinical form of leukoencephalopathy with ataxia (LKPAT)

Catalog

Books, media, physical & digital resources